|
1) |
Hull GW, Rabbani F, Abbas F, et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002;167:528-34. |
2) |
Brandli DW, Koch MO, Foster RS, et al. Biochemical disease-free survival in patients with a high prostate-specific antigen level(20-100ng/mL)and clinically localized prostate cancer after radical prostatectomy. BJU Int. 2003;92(1):19-22;discussion 22-3. |
3) |
Mian BM, Troncoso P, Okihara K, et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol. 2002;167(4):1675-80. |
4) |
Lau WK, Bergstralh EJ, Blute ML, et al. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer:influence of concomitant pathological variables. J Urol. 2002;167(1):117-22. |
5) |
Sweat SD, Bergstralh EJ, Slezak J, et al. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol. 2002;168(2):525-9. |
6) |
Manoharan M, Bird VG, Kim SS, et al. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8. BJU Int. 2003;92(6):539-44. |